Stokes & Hubbell Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.8M	Buy	37,752 +8	+0%	+$399	0.38%	56
2018 Q4	$1.96M	Sell	37,744 -704	-2%	-$37.8K	0.44%	49
2018 Q3	$2.39M	Buy	38,448 +2,954	+8%	+$175K	0.49%	49
2018 Q2	$1.96M	Sell	35,494 -2,609	-7%	-$141K	0.44%	50
2018 Q1	$2.41M	Buy	38,103 +87	+0.2%	+$5.6K	0.56%	47
2017 Q4	$2.33M	Buy	38,016 +158	+0.4%	+$9.88K	0.56%	46
2017 Q3	$2.41M	Buy	37,858 +21,926	+138%	+$1.28M	0.62%	44
2017 Q2	$888K	Buy	15,932 +2,632	+20%	+$143K	0.27%	58
2017 Q1	$723K	Buy	13,300 +206	+2%	+$11.3K	0.25%	60
2016 Q4	$765K	Buy	13,094 +2,855	+28%	+$156K	0.3%	54
2016 Q3	$552K	Buy	10,239 +4	+0%	+$257	0.23%	61
2016 Q2	$753K	Buy	10,235 +953	+10%	+$67.3K	0.32%	50
2016 Q1	$593K	Buy	9,282 +1,049	+13%	+$66.2K	0.27%	49
2015 Q4	$566K	Buy	8,233 +3	+0%	+$198	0.31%	49
2015 Q3	$487K	Buy	+8,230	New	+$522K	0.3%	48